Clearant Sterilization Method Aimed At Musculoskeletal Tissue Processors
This article was originally published in The Gray Sheet
Executive Summary
Clearant, Inc. is looking to develop licensing agreements for its Clearant sterilzation process with a number of tissue processing companies in the coming year, addressing a $650-750 mil. U.S. musculoskeletal tissue market